172 related articles for article (PubMed ID: 31857571)
21. Acute kidney injury associated with smoking synthetic cannabinoid.
Buser GL; Gerona RR; Horowitz BZ; Vian KP; Troxell ML; Hendrickson RG; Houghton DC; Rozansky D; Su SW; Leman RF
Clin Toxicol (Phila); 2014 Aug; 52(7):664-73. PubMed ID: 25089722
[TBL] [Abstract][Full Text] [Related]
22. Determination of urinary metabolites of XLR-11 by liquid chromatography-quadrupole time-of-flight mass spectrometry.
Jang M; Kim IS; Park YN; Kim J; Han I; Baeck S; Yang W; Yoo HH
Anal Bioanal Chem; 2016 Jan; 408(2):503-16. PubMed ID: 26514671
[TBL] [Abstract][Full Text] [Related]
23. Tentative identification of the metabolites of (1-(cyclohexylmethyl)-1H-indol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone, and the product of its thermal degradation, by in vitro and in vivo methods.
Grigoryev A; Kavanagh P; Labutin A; Pechnikov A; Dowling G; Shevyrin V; Krupina N
Drug Test Anal; 2019 Sep; 11(9):1387-1402. PubMed ID: 31243890
[TBL] [Abstract][Full Text] [Related]
24. Takotsubo-like syndrome triggered by fludrocortisone overdose for Addison's disease: a case report.
Campean R; Hasun M; Stöllberger C; Bucher J; Finsterer J; Schnack C; Weidinger F
J Med Case Rep; 2016 Oct; 10(1):281. PubMed ID: 27729057
[TBL] [Abstract][Full Text] [Related]
25. A spicy status: Synthetic cannabinoid (spice) use and new-onset refractory status epilepticus-A case report and review of the literature.
Babi MA; Robinson CP; Maciel CB
SAGE Open Med Case Rep; 2017; 5():2050313X17745206. PubMed ID: 29238581
[TBL] [Abstract][Full Text] [Related]
26. A Fast and Comprehensive Analysis of 32 Synthetic Cannabinoids Using Agilent Triple Quadrupole LC-MS-MS.
Borg D; Tverdovsky A; Stripp R
J Anal Toxicol; 2017 Jan; 41(1):6-16. PubMed ID: 27681343
[TBL] [Abstract][Full Text] [Related]
27. Teens and Spice: A Review of Adolescent Fatalities Associated with Synthetic Cannabinoid Use.
Paul ABM; Simms L; Amini S; Paul AE
J Forensic Sci; 2018 Jul; 63(4):1321-1324. PubMed ID: 29194599
[TBL] [Abstract][Full Text] [Related]
28. Separation and structural characterization of the new synthetic cannabinoid JWH-018 cyclohexyl methyl derivative "NE-CHMIMO" using flash chromatography, GC-MS, IR and NMR spectroscopy.
Angerer V; Bisel P; Moosmann B; Westphal F; Auwärter V
Forensic Sci Int; 2016 Sep; 266():e93-e98. PubMed ID: 27297324
[TBL] [Abstract][Full Text] [Related]
29. Synthetic Cannabinoid Abuse in Adolescents: A Case Series.
Besli GE; Ikiz MA; Yildirim S; Saltik S
J Emerg Med; 2015 Nov; 49(5):644-50. PubMed ID: 26293411
[TBL] [Abstract][Full Text] [Related]
30. AB-CHMINACA, AB-PINACA, and FUBIMINA: Affinity and Potency of Novel Synthetic Cannabinoids in Producing Δ9-Tetrahydrocannabinol-Like Effects in Mice.
Wiley JL; Marusich JA; Lefever TW; Antonazzo KR; Wallgren MT; Cortes RA; Patel PR; Grabenauer M; Moore KN; Thomas BF
J Pharmacol Exp Ther; 2015 Sep; 354(3):328-39. PubMed ID: 26105953
[TBL] [Abstract][Full Text] [Related]
31. New challenges in toxicology of new psychoactive substances exemplified by fatal cases after UR-144 and UR-144 with pentedrone administration determined by LC-ESI-MS-MS in blood samples.
Rojek S; Korczyńska-Albert M; Kulikowska J; Kłys M
Arch Med Sadowej Kryminol; 2017; 67(2):104-120. PubMed ID: 29363897
[TBL] [Abstract][Full Text] [Related]
32. Toxicological findings of synthetic cannabinoids in recreational users.
Kronstrand R; Roman M; Andersson M; Eklund A
J Anal Toxicol; 2013 Oct; 37(8):534-41. PubMed ID: 23970540
[TBL] [Abstract][Full Text] [Related]
33. Schedules of controlled substances: temporary placement of three synthetic cannabinoids into Schedule I. Final order.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2013 May; 78(95):28735-9. PubMed ID: 23678676
[TBL] [Abstract][Full Text] [Related]
34. Pyrolysis of UR-144, a synthetic cannabinoid, augments an affinity to human CB
Kaizaki-Mitsumoto A; Hataoka K; Funada M; Odanaka Y; Kumamoto H; Numazawa S
J Toxicol Sci; 2017; 42(3):335-341. PubMed ID: 28496039
[TBL] [Abstract][Full Text] [Related]
35. Cannabinoid
Skolnick P; Crystal R
J Neural Transm (Vienna); 2020 Feb; 127(2):279-286. PubMed ID: 31893308
[TBL] [Abstract][Full Text] [Related]
36. Identification of synthetic cannabinoids that were seized, consumed, or associated with deaths in Kuwait in 2018 using GC-MS and LC-MS-MS analysis.
Al-Matrouk A; Alqallaf M; AlShemmeri A; BoJbarah H
Forensic Sci Int; 2019 Oct; 303():109960. PubMed ID: 31550599
[TBL] [Abstract][Full Text] [Related]
37. Occurrence of Takotsubo Cardiomyopathy after Synthetic Cannabinoid Consumption.
Mohammed D
Addict Health; 2019 Jul; 11(3):202-206. PubMed ID: 31839918
[TBL] [Abstract][Full Text] [Related]
38. Takotsubo cardiomyopathy triggered by status epilepticus: case report and literature review.
Nandal S; Castles A; Asrar Ul Haq M; van Gaal W
BMJ Case Rep; 2019 Jan; 12(1):. PubMed ID: 30700451
[TBL] [Abstract][Full Text] [Related]
39. The impact of the 2016 Psychoactive Substances Act on synthetic cannabinoid use within the homeless population: Markets, content and user harms.
Ralphs R; Gray P; Sutcliffe OB
Int J Drug Policy; 2021 Nov; 97():103305. PubMed ID: 34146792
[TBL] [Abstract][Full Text] [Related]
40. Concentrations of APINACA, 5F-APINACA, UR-144 and its degradant product in blood samples from six impaired drivers compared to previous reported concentrations of other synthetic cannabinoids.
Karinen R; Tuv SS; Øiestad EL; Vindenes V
Forensic Sci Int; 2015 Jan; 246():98-103. PubMed ID: 25485949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
